[Congenital and acquired cholesteatoma middle ear in children]

Jerzy Kuczkowski1, Dariusz Babiński, Dominik Stodulski

  • 1Katedra i Klinika Chorób Uszu, Nosa, Gardła i Krtani AM, Gdańsku. jerzyk@amedec.amg.gda.pl

Insights

Pediatric middle ear cholesteatoma, often causing hearing loss, requires early diagnosis and treatment. Optimal outcomes for children with cholesteatoma are achieved through early intervention and open tympanoplasty.

Area of Science:

  • Otolaryngology
  • Pediatric Otology
  • Medical Research

Background:

  • Cholesteatoma of the middle ear in children can lead to hypoacusis (hearing loss).
  • Early diagnosis and effective treatment are crucial for achieving favorable functional results.
  • This study reviews a cohort of pediatric patients treated for middle ear cholesteatoma.

Purpose of the Study:

  • To analyze the clinical characteristics, treatment modalities, and outcomes of middle ear cholesteatoma in children.
  • To evaluate the effectiveness of different surgical approaches and identify factors influencing treatment success.
  • To highlight the importance of early detection and intervention in managing pediatric cholesteatoma.

Main Methods:

  • Retrospective analysis of 57 children (58 ears) diagnosed with middle ear cholesteatoma between 1991 and 2002.
  • Data collected included patient age, cholesteatoma type (acquired vs. congenital), location, presenting symptoms, audiological evaluation (air-bone gap), bacteriology, imaging findings, surgical procedures, complications, and recurrence rates.
  • Surgical interventions included radical surgery, modified radical mastoidectomy, and tympanoplasty.

Main Results:

  • The majority of cases were acquired cholesteatoma (89.6%) in children aged 11-15 years.
  • Hearing loss (98.3%) and purulent otorrhea (85.4%) were the most common symptoms.
  • Post-treatment, mean air-bone gap improved in acquired cholesteatoma (18.7 dB to 15.7 dB) but showed minimal change in congenital cases (13.6 dB to 14 dB).
  • Complications included intracranial (2), intratemporal (2), and extracranial (1).
  • Purulent otorrhea was the most frequent failure (36.2%), and reoperation for recurrence was performed in 29.3% of cases.
  • Improved or stable hearing was achieved in 60.3% of ears.

Conclusions:

  • Middle ear cholesteatoma in children presents diagnostic and therapeutic challenges due to its insidious onset, aggressive growth, and high recurrence rate.
  • Early clinical detection and management, particularly with open tympanoplasty procedures, are associated with the best treatment outcomes.
  • Aggressive surgical management and close follow-up are essential for minimizing complications and recurrence in pediatric cholesteatoma.